2 Stifel, Obesity drug review, market update July 1st, 2023, 3 Goldman Sachs Research
Conclusions The study documented benefits of semaglutide on metabolic control and multiple CV risk factors, simplification of therapeutic schemes and high satisfaction with diabetes treatment, and eating behaviors indicative of healthy diet and reduced food intake
In one trial , participants lost nearly 11% of their body weight with weekly semaglutide injections, dietary changes, exercise, and psychological counseling
Therefore, glycine must be readily available with so many important metabolic functions
The main thing is to keep up with treatment and watch closely for the best results
KFF (Kaiser Family Foundation)